{"nct_id":"NCT02269917","title":"Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2015-03","start_date_type":"ACTUAL","primary_completion_date":"2017-02","primary_completion_date_type":"ACTUAL","completion_date":"2020-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}